DMAC - DiaMedica Therapeutics Inc.

QQQ $ 634.19 $ 0.00 (0 %)

DIA $ 475.22 $ 0.00 (0 %)

SPY $ 684.94 $ 0.00 (0 %)

TLT $ 90.24 $ 0.00 (0 %)

GLD $ 368.38 $ 0.00 (0 %)

Previous Close

$ 7

Open

$ 6.85

Bid

$ 6.51 x 26

Ask

$ 7.15 x 2,500

Day's Range

-- - --

52 Week Range

$ 3.19 - $ 7.49

Volume

295,836

Average Volume

Market Cap

361.82M

Beta (5Y Monthly)

$ 0.91

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-13-2025	03-31-2025	10-Q
3	03-17-2025	12-31-2024	10-K
4	11-13-2024	09-30-2024	10-Q
5	08-07-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	03-19-2024	12-31-2023	10-K
8	11-13-2023	09-30-2023	10-Q
9	08-14-2023	06-30-2023	10-Q
10	05-15-2023	03-31-2023	10-Q
11	03-28-2023	12-31-2022	10-K
12	11-09-2022	09-30-2022	10-Q
13	08-10-2022	06-30-2022	10-Q
14	05-04-2022	03-31-2022	10-Q
15	03-14-2022	12-31-2021	10-K
16	11-10-2021	09-30-2021	10-Q
17	08-11-2021	06-30-2021	10-Q
18	05-05-2021	03-31-2021	10-Q
19	03-10-2021	12-31-2020	10-K
20	11-04-2020	09-30-2020	10-Q
21	08-11-2020	06-30-2020	10-Q
22	05-13-2020	03-31-2020	10-Q
23	03-23-2020	12-31-2019	10-K
24	11-13-2019	09-30-2019	10-Q
25	08-13-2019	06-30-2019	10-Q
26	05-13-2019	03-31-2019	10-Q
27	03-19-2019	12-31-2018	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Wednesday'...
10/15/2025 12:09:47

12 Health Care Stocks Moving In Monday's A...
08/18/2025 21:06:13

HC Wainwright & Co. Reiterates Buy on DiaM...
08/15/2025 11:11:34

HC Wainwright & Co. analyst Matthew Caufield reiterates DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and maintains $1...

DiaMedica Therapeutics Enters Sales Agreem...
08/12/2025 21:37:38

-SEC Filing

DiaMedica Therapeutics Q2 EPS $(0.18) Beat...
08/12/2025 20:15:57

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate o...

Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

Exploring DiaMedica Therapeutics's Earning...
08/11/2025 19:02:56

Craig-Hallum Maintains Buy on DiaMedica Th...
07/18/2025 15:57:35

Craig-Hallum analyst Chase Knickerbocker maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the price targ...

Lake Street Maintains Buy on DiaMedica The...
07/18/2025 15:48:28

Lake Street analyst Thomas Flaten maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the price target from...

HC Wainwright & Co. Maintains Buy on DiaMe...
07/18/2025 10:51:16

HC Wainwright & Co. analyst Matthew Caufield maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the pr...

DiaMedica Therapeutics Announces Interim R...
07/17/2025 12:20:31

Conference Call Today July 17, 2025 at 4:30 PM Eastern Time / 3:30 PM Central TimeDM199 Demonstrated Highly Statistically Signi...

HC Wainwright & Co. Reiterates Buy on DiaM...
05/29/2025 11:34:43

HC Wainwright & Co. analyst Matthew Caufield reiterates DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and maintains $1...

DiaMedica Therapeutics Announces Key Opini...
05/19/2025 13:06:05

Company to Host Preeclampsia Key Opinion Leader Event May 28, 2025 at 8 AM Eastern / 7 AM CentralDiaMedica Therapeutics Inc. (N...

DiaMedica Therapeutics Q1 EPS $(0.18), Inline
05/13/2025 20:30:52

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.18) per share which met the analyst consensus estimate. T...

Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

Insights Ahead: DiaMedica Therapeutics's Q...
05/12/2025 20:09:32

why-ericsson-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket

Why Ericsson Shares Are Trading Higher By ...
04/15/2025 09:19:09

HC Wainwright & Co. Maintains Buy on DiaMe...
03/19/2025 10:45:25

HC Wainwright & Co. analyst Matthew Caufield maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the pr...

DiaMedica Therapeutics FY 2024 GAAP EPS $(...
03/17/2025 20:31:02

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate...

Earnings Scheduled For March 17, 2025
03/17/2025 08:32:11